Drug Profile
Research programme: antidepressants - Clera
Alternative Names: Clera 103; Clera 301; CLR 200Latest Information Update: 21 Jan 2014
Price :
$50
*
At a glance
- Originator Clera
- Class Small molecules
- Mechanism of Action Dopamine uptake inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 21 Jan 2014 Discontinued - Preclinical for Major depressive disorder in Canada (PO)
- 12 Jul 2010 Preclinical trials in Depression in Canada (PO)
- 29 Jun 2004 This programme is available for licensing(http://www.clera.com)